Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.45 - $1.57 $20,767 - $72,453
-46,149 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.29 - $1.85 $17,222 - $24,699
-13,351 Reduced 22.44%
46,149 $66,000
Q2 2021

Aug 11, 2021

BUY
$1.72 - $3.19 $81,737 - $151,595
47,522 Added 396.74%
59,500 $185,000
Q1 2021

May 13, 2021

SELL
$1.73 - $3.33 $75,722 - $145,754
-43,770 Reduced 78.51%
11,978 $28,000
Q4 2020

Feb 16, 2021

SELL
$1.67 - $2.63 $113,147 - $178,190
-67,753 Reduced 54.86%
55,748 $97,000
Q3 2020

Nov 12, 2020

BUY
$2.11 - $3.52 $242,696 - $404,877
115,022 Added 1356.55%
123,501 $287,000
Q2 2020

Aug 13, 2020

BUY
$2.52 - $4.76 $21,367 - $40,360
8,479 New
8,479 $30,000

Others Institutions Holding VERO

# of Institutions
1
Shares Held
7K
Call Options Held
0
Put Options Held
0

About Venus Concept Inc.


  • Ticker VERO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 65,459,600
  • Market Cap $20.3M
  • Description
  • Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device us...
More about VERO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.